08.00 Endovascular treatment of carotid artery occlusion in acute stroke, K. Mathias
08.07 Stenting of carotid dissection at the acute phase, E. Houdart
08.14 Carotid stenting in subtotal carotid stenosis, I. Petrov
08.21 OCT evaluation of micromesh carotid stend, J. Lemoine
08.28 CAS 2014 : where are we for symptomatic patients? N. Hopkins
08.35 CAS 2014 : where are we for asymptomatic patients? A. Halliday
08.42 Simultaneous bilateral carotid artery stenting vs unilateral carotid artery stenting:
early and long-term results, X. Jiang
08.54 Why asymptomatic carotid stenoses should be treated, C. Buckley
09.01 Flow reversal for carotid protection in difficult cases: tips and tricks, P. Montorsi
09.08 Discussion
09.12 A new area for CAS with a novel stent, M. Amor
09.19 A safe cervical access for CAS using US guidance and closing device, P. Bergeron
09.26 Endovascular treatment of a giant extra cranial carotid artery aneurysm, Z. Krajcer
09.33 A Silk Road case, N. Hopkins
09.40 Discussion
10.30 Coffee break in the exhibition hall
11.00 If you don’t have an effective follow-up program, don’t do EVAR, M. Thompson
11.07 Not every EVAR patient needs strict follow-up, R. McWilliams
11.14 Vote & discussion
11.20 Case presentation with interactive voting, A. Mansilha
11.27 Enlargement of the proximal neck, P. Cao, C. Ferrer
11.34 FEVAR, T. Resch
11.41 Endoanchors are the way forward, J-P. De Vries
11.48 Chimps, M. Lachat
11.55 Vote & discussion
12.02 Treatment of type II endoleak, J. Van Den Berg
12.09 Why not prevent endoleaks before they become a frustrating problem? C. Buckley
12.16 EVAS: initial experience with NELLIX, J-M. Alsac
12.23 Late results of secondary interventions for endoleaks, F. Verzini
12.27 Intentional occlusion of fenestrations and sidebranches for endoleak treatment: incidence, underlying reasons and techniques, J. Tessarek
12.34 Rescue EVAR for ruptured AAA: clinical success doesn’t meen technical success, F. Setacci
12.41 Discussion
12.48 PET-CT in the follow-up of EVAR-treated AAA complicated by aorto-duodenal fistula, N. Sakalihasan
12.55 Conservative, endovascular relining or conversion, L. Chiche
13.02 Discussion
13.15 Lunch break
15.45 Coffee break in the exhibition hall
17.00 What is the place today of renal angioplasty, A. Sauguet
17.10 Rational for the renal denervation in resistant hypertension, A. Pathak
17.20 Results and a French experience of renal denervation in resistant hypertension, H. Benamer
17.30 Anatomic datas in renal denervation, M. Amor
17.40 Simple to complex renal denervation cases, H. Benamer
17.50 Discussion
18.30 End of the sessions